A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
University of Colorado, Denver
Sarcoma Alliance for Research through Collaboration
University of Miami
Grupo Espanol de Investigacion en Sarcomas
Xiangya Hospital of Central South University
Dana-Farber Cancer Institute
Columbia University
Shanghai Zhongshan Hospital
Center Trials & Treatment
Heidelberg University
University of Alabama at Birmingham
Cantonal Hospital of St. Gallen
Memorial Sloan Kettering Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Vanderbilt-Ingram Cancer Center
Australasian Sarcoma Study Group